Comment to: Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomized, placebo-controlled trial, Kirsner RS et al. Lancet 2012;380:977-8.
Submitted: 18 September 2013
Accepted: 18 September 2013
Published: 20 December 2013
Accepted: 18 September 2013
Abstract Views: 1479
FULL TEXT: 1060
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Ricci, S. (2013). Comment to: Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomized, placebo-controlled trial, Kirsner RS et al. Lancet 2012;380:977-8. Veins and Lymphatics, 2(1), 8. https://doi.org/10.4081/ByblioLab.2013.8
Copyright (c) 2013 Stefano Ricci
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.